(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) jumped 9.45% to $3.36 at 10:26 EST on Monday, after three successive sessions in a row of gains. NASDAQ is sliding 0.77% to $11,714.45, after two sequential sessions in a row of gains. This seems, up to now, a somewhat bearish trend exchanging session today.

TherapeuticsMD’s last close was $3.07, 11.64% above its 52-week high of $2.75.


Today’s last reported volume for TherapeuticsMD is 200998 which is 18.92% below its average volume of 247910.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the present quarter and 29.3% for the next. The company’s growth estimates for the present quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.


TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 12.82%, a negative 5.99%, and a positive 7.20%, respectively.

TherapeuticsMD’s highest amplitude of average volatility was 14.33% (last week), 7.08% (last month), and 7.20% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $3.36 at 10:26 EST, way higher than its 52-week high of $2.75.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way higher than its 50-day moving average of $0.66 and way higher than its 200-day moving average of $1.00.

More news about TherapeuticsMD (TXMD).


Please enter your comment!
Please enter your name here